Search Results

You searched for : CancerImmunotherapy

	Takeda acquires Maverick Therapeutics for around $ 525 million benefit Takeover to advance T-Cell Activator Solid Tumor Treatments and expand new Cancer Immunotherapy Portfolio... Mar 13
	Sorrento receives USFDA clearance to start a clinical trial of Anti-CD47 antibody Sorrento receives USFDA clearance to start a clinical trial of Anti-CD47 Antibody, discovered from fully human G-MAB library, for treatment of multiple malignancies ... Mar 03
	Compugen expands clinical collaboration agreement with Bristol Myers Squibb Compugen Ltd expands collaboration agreement with Bristol Myers Squibb with phase 1b combination study of COM701 with opdivo C... Feb 22
	Blueprint Medicines submits sNDA to USFDA for AYVAKIT for the treatment of advanced systemic mastocytosis Blueprint Medicines requested priority review for this application, which, if granted, could result in a six-month review process... Dec 18
	Pierre Fabre and Y-Biologics are jointly researching new immunotherapies based on monoclonal antibodies The two partners want to pool their expertise in order to identify and develop new monoclonal antibodies for cancer therapy... Nov 24
	Compugen Reports 4th Quarter and Full Year 2019 Result Compugen Ltd., a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today declared their 4th and full year report.... Feb 21
6 Matching result(s) found!

-Advertisements-

Trending Now
	Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
	International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
	The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
	Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
	Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
	In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
	Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
	Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
	10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
	Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
	The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
	Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
	A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
	The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
	ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
	The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
	Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
	Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
	AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
	Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024

Search Results

Takeda acquires Maverick Therapeutics for around $ 525 million benefit

Sorrento receives USFDA clearance to start a clinical trial of Anti-CD47 antibody

Compugen expands clinical collaboration agreement with Bristol Myers Squibb

Blueprint Medicines submits sNDA to USFDA for AYVAKIT for the treatment of advanced systemic mastocytosis

Pierre Fabre and Y-Biologics are jointly researching new immunotherapies based on monoclonal antibodies

Compugen Reports 4th Quarter and Full Year 2019 Result

Trending Now